Award recordCONTRACT

EXELAN PHARMACEUTICALS INC

PIID 36C26326N0313· VHA· NETWORK CONTRACT OFFICE 23 (36C263)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $1,315,307 net obligations· UEI FYZXNHSQTMG8· FL

Description

GENERIC LENALIDOMIDE DRUG

First action · last action
2026-01-01 · 2026-07-16
Transactions
3
First transaction's obligation
$1,439,279
Base + all options value (sum of deltas)
$1,315,307
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
2
SDVOSB flag on record
No
Parent IDV
36F79720D0227
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1,540,929$0Base award · 2026-01-01 · this action $1,439,279 · running total $1,439,279Modification P00001 · 2026-01-27 · this action $101,649 · running total $1,540,929Modification P00002 · 2026-07-16 · this action -$225,622 · running total $1,315,307
  • Base2026-01-01+$1,439,279= $1,439,279
  • Mod P000012026-01-27+$101,649= $1,540,929
  • Mod P000022026-07-16-$225,622= $1,315,307
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2026-01-01+$1,439,279$1,439,279GENERIC LENALIDOMIDE DRUG
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-01-27+$101,649$1,540,929GENERIC LENALIDOMIDE DRUG
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-07-16−$225,622$1,315,307GENERIC LENALIDOMIDE DRUG

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FYZXNHSQTMG8)

AwardOffice · PSC / listingNet obligationsFY
36C24226N0564242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$5,337,256FY2026
36C25926F0197NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$1,844,059FY2026
36C26026F0261260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$918,831FY2026
36E79726D0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0169260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$712,808FY2026
36C24426N0400244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$1,487,248FY2026

Other recipients under 6505 from NETWORK CONTRACT OFFICE 23 (36C263) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26326F0080MEDI-PHYSICS, INC.NETWORK CONTRACT OFFICE 23 (36C263)$27,788FY2026
36C26326N0517HOT SHOTS NM LLCNETWORK CONTRACT OFFICE 23 (36C263)$87,320FY2026
36C26326D0053HOT SHOTS NM LLCNETWORK CONTRACT OFFICE 23 (36C263)$0FY2026
36C26326P0460PROFOUNDA INCNETWORK CONTRACT OFFICE 23 (36C263)$49,950FY2026
36C26326N0416CARDINAL HEALTH 414, LLCNETWORK CONTRACT OFFICE 23 (36C263)$761,773FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26326N0313_3600_36F79720D0227_3600 · retrieved 2026-09-26.